# Ovid Therapeutics Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 10-K/A
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:06 ET
- Period: 2024-12-31
- Accession: 0001628280-25-021055
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000162828025021055/ovid-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000162828025021055/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000162828025021055/ovid-20241231.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-021055. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.